Search clinical trials for: Ruxolitinib Oral Tablet

Total 13975 results

Institut Bergonié
Novartis

Terminated

Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response (MIM)

Leukemia, Myeloid, Chronic-Phase

France
University of Electronic Science and Technology...

Unknown

The Effects of Losartan on Social Reward

Healthy

China
University of Electronic Science and Technology...

Unknown

The Effects of Losartan on Reward Reinforcement Learning

Healthy

China
University of Massachusetts, Amherst

Withdrawn

O2 Transport and Utilization in Health and Lung Disease

Oxidative Stress | COPD | Tetrahydrobiopterin Deficiency

United States
Albireo

Completed

A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH

NAFLD | NASH

United States
University of Louisville
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis

Mild to Moderately Active Ulcerative Colitis

United States
Takeda

Completed

A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants

Healthy Volunteers

United States
Cosmo Technologies Ltd

Completed

Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

Polyp and Adenoma Detection During Colonoscopy
Aarhus University Hospital
Odense University Hospital; Rigshospitalet, Denmark; University of Copenhagen; Herning... and other collaborators

Recruiting

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Breast Cancer Female | Estrogen Receptor Positive Tumor

Denmark
University of Michigan Rogel Cancer Center

Withdrawn

Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype

CYP3A4*22
University of Electronic Science and Technology...

Unknown

Losartan and Emotion Processing

Healthy

China
Shanghai Zhongshan Hospital

Active, not recruiting

Remission of Type 2 Diabetes With Dapagliflozin (READ Trial) (READ)

Type 2 Diabetes

China
Saint Luke's Health System

Completed

Dapagliflozin in PRESERVED Ejection Fraction Heart Failure (PRESERVED-HF)

Chronic Heart Failure With Preserved Systolic Function

United States
University of Electronic Science and Technology...

Unknown

Losartan Effects on Emotion-memory Interaction

Healthy

China
Assistance Publique Hopitaux De Marseille

Unknown

A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease (INFLAMMACOV)

Covid19

France
Overseas Pharmaceuticals, Ltd.
GX pharma technology (beijing) Co., Ltd

Active, not recruiting

An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.

Partial Seizure

China
Kartos Therapeutics, Inc.

Recruiting

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib

Myelofibrosis

United States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
Incyte Corporation
Innovaderm Research

Completed

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Atopic Dermatitis

United States
The First Affiliated Hospital of Soochow University

Unknown

Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia

Safety and Efficacy

China
University of Cologne

Completed

JAK-inhibition in Recurrent Classical Hodgkin Lymphoma (JeRiCHO)

Recurrent Classical Hodgkin Lymphoma

Germany
University of Florida

Recruiting

The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults

Pain

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI); National Institute on Aging... and other collaborators

Recruiting

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE)

Cardiovascular Diseases | Dementia | Cognitive Impairment, Mild

United States, Puerto Rico
University of Cincinnati
Procter and Gamble

Completed

Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol) (SABER-C)

COVID-19 | Diarrhea

United States
University of Manitoba

Recruiting

Measurement of the Hippocampal Theta Rhythm From the Outer Ear Canal

Anxiety

Canada
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

JAK Inhibitor in Acquired Hemophagocytic synDrome in the Intensive Care Unit (JAKAHDI)

Hemophagocytic Syndromes
Institute of Hematology & Blood Diseases Hospital

Recruiting

Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model

Transplant-Related Disorder

China
Institute of Hematology & Blood Diseases Hospital

Recruiting

Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model

Transplant-Related Disorder

China
Karyopharm Therapeutics Inc

Recruiting

Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis (SENTRY)

Myelofibrosis

United States, Korea, Republic of, Belgium, Italy, Spain, France, United Kingdom, Israel, Czechia, Taiwan, Canada, Germany, Romania, Bulgaria, Poland, Denmark
Incyte Corporation

Completed

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

Atopic Dermatitis

United States, Canada
Incyte Corporation

Terminated

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

MPN (Myeloproliferative Neoplasms)

United States
Xenikos
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Terminated

A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) (2002)

Steroid-Refractory Acute Graft Versus Host Disease

United States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
Incyte Corporation

Completed

A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis

Psoriasis

United States
Incyte Corporation

Completed

A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Novartis Pharmaceuticals

Completed

Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial

Myelofibrosis

France, United Kingdom, Belgium, Germany, Netherlands, Italy, Austria, Spain, Sweden
Novartis Pharmaceuticals

Completed

A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis

Primary Myelofibrosis (MF)

Japan
Ain Shams University

Unknown

Effect of Magnesium Supplement in Early Pregnancy After ICSI

ICSI

Egypt
AstraZeneca

Completed

Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects (BA)

Healthy Volunteers | Pharmacologic Action

United States
GlaxoSmithKline

Completed

GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol

Dyslipidaemia | Dyslipidaemias

Germany, Estonia, Belgium, France, Netherlands, Denmark, Portugal, Norway, Sweden, Lithuania, Finland
French Innovative Leukemia Organisation

Completed

JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis

Myelofibrosis

France
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease

Kohlmeier Degos Disease With Neurologic Involvement

United States
Assiut University

Not yet recruiting

Ruxolitinib in Patients With Myelofibrosis

Myelofibrosis
University of Nebraska

Completed

Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids

Graft-versus-host-disease (GVHD)

United States
Gilead Sciences

Completed

Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis

Myelofibrosis

United States
Washington University School of Medicine
Incyte Corporation

Withdrawn

Ruxolitinib to Combat COVID-19

COVID-19
AstraZeneca

Completed

Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma Centres (BPAP)

Asthma

United Kingdom
Auris Medical AG

Completed

AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery (TRAVERS)

Vestibular Vertigo

France
Mclean Hospital

Active, not recruiting

Rebalancing the Serotonergic System in Cocaine Dependence

Cocaine Dependence

United States
Weill Medical College of Cornell University

Completed

Efficacy of Enteral Iron Supplementation in Critical Illness

Anemic, Critically Ill Patients

United States
University of California, Davis

Completed

Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin

Erythema | Wrinkles | Transepidermal Water Loss | Sebum Production | Stool Microbiome | Facial Brrightness | Facial Shine

United States
Jennifer Keiser
Centre Suisse de Recherches Scientifiques en Cote d'Ivoire

Completed

Efficacy and Safety of MOX/ALB Co-administration

Hookworm Infections | Ascariasis | Trichuriasis

Côte D'Ivoire

Search clinical trials for: Ruxolitinib Oral Tablet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations